Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on November 20,2024 GUANGZHOU,China,Nov. 20,2024-- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leadin
11-21
FLORENCE,Italy,Nov. 20,2024-- The journey of the28th Fair Play Menarini International Award continues. Following the spectacular award ceremony on 4 July,the event honouring the pinnacle of loyalty a
11-21
BEIJING,Nov. 20,2024-- A news report bychinadiplomacy.org.cn on China-Pakistan cooperation through the China-Pakistan Economic Corridor (CPEC):
11-21
The collaboration will accelerate the global development of LAE102,a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preserving weight loss in Obesity
11-21
MATARAM,Indonesia,Nov. 21,2024-- After running for two years,the "Integrated Farming System" development program,based on local potential in the Mandalika Special Economic Zone (SEZ) buffer
11-21
HONG KONG,Nov. 21,2024-- Kerry Logistics Network Limited (\'KLN\'; Stock Code 0636.HK)is pleased to announce the appointment of Wong Siew Loong as its Chief Commercial Officer for the Group and Managi
11-21
BAKU,Azerbaijan,Nov. 19,2024-- At a critical moment for global climate action,Chinesecorporates are responding to the theme of COP29,"Enhancing Ambition,Implementing Action," with concrete a
11-20
TAIPEI,Nov. 19,2024-- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product,TAH3311,an innovative antithrombotic oral dissolvin
11-20
SEOUL,South Korea,Nov. 20,2024-- Binggrae,South Korea\'s leading food company,has announced that its flagship ice bar,Melona,is now available at Costco in Australia starting this month.
11-20
SHANGHAI,Nov. 20,2024-- On November 13th,a high-level delegation from the Alfasigma Group,led by Mr. Andriy Samoylovych,Chief Commercial Officer of Global Growth Markets,and Ms. Zhou Qin,General Mana
11-20
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
